| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -8.1e-05 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -1.8e-05 | 1 |